109 related articles for article (PubMed ID: 38780072)
1. Single-nucleotide polymorphism array and fluorescence in situ hybridization analysis to decode the cytogenetic profile of atypical partial hydatidiform moles diagnosed by short tandem repeat polymorphism analysis.
Suzuki Y; Usui H; Katayama E; Sato A; Nakamura N; Nakada E; Omoto A; Okayama J; Sato M; Nagasawa A; Hirosawa A; Shozu M; Koga K
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23220. PubMed ID: 38780072
[TBL] [Abstract][Full Text] [Related]
2. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
3. Comparison Between Pathological Diagnosis and Cytogenetic Diagnosis by Short Tandem Repeat Polymorphism Analysis of Suspected Molar Pregnancies.
Usui H; Kiyokawa T; Qu J; Nishikimi K; Tate S; Mitsuhashi A; Nakatani Y; Shozu M
J Reprod Med; 2016; 61(5-6):219-23. PubMed ID: 27424362
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Combined p57KIP2 Immunohistochemistry and Fluorescent in situ Hybridization Analysis for Hydatidiform Moles Compared with Genotyping Diagnosis.
Usui H; Hoshimoto K; Sato A; Kano M; Fukusato T; Nakatani Y; Shozu M
Int J Gynecol Pathol; 2024 Jan; ():. PubMed ID: 38291567
[TBL] [Abstract][Full Text] [Related]
5. Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.
Xing D; Adams E; Huang J; Ronnett BM
Mod Pathol; 2021 May; 34(5):961-982. PubMed ID: 33024305
[TBL] [Abstract][Full Text] [Related]
6. Auxiliary and experimental diagnostic techniques for hydatidiform moles.
Usui H
J Obstet Gynaecol Res; 2022 Dec; 48(12):3077-3086. PubMed ID: 36098274
[TBL] [Abstract][Full Text] [Related]
7. Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study.
Usui H; Qu J; Sato A; Pan Z; Mitsuhashi A; Matsui H; Shozu M
Int J Gynecol Cancer; 2018 Nov; 28(9):1772-1780. PubMed ID: 30358702
[TBL] [Abstract][Full Text] [Related]
8. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization.
Chiang S; Fazlollahi L; Nguyen A; Betensky RA; Roberts DJ; Iafrate AJ
J Mol Diagn; 2011 Jul; 13(4):406-15. PubMed ID: 21704275
[TBL] [Abstract][Full Text] [Related]
10. [Clinical application of STR genotyping diagnosis for hydatidiform mole and nonmolar gestation].
Zheng XZ; Qin XY; Wang P; Xu F; Ma JH; Wang XL; Chen SW; Feng WQ; Zhu L; Yin CH; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):609-615. PubMed ID: 30107666
[No Abstract] [Full Text] [Related]
11. [Diagnostic utility of STR genotyping for partial hydatidiform moles].
Chang B; Lu L; Zheng X; Qin X
Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):868-73. PubMed ID: 26888503
[TBL] [Abstract][Full Text] [Related]
12. Hydatidiform moles: ancillary techniques to refine diagnosis.
Ronnett BM; DeScipio C; Murphy KM
Int J Gynecol Pathol; 2011 Mar; 30(2):101-16. PubMed ID: 21293291
[TBL] [Abstract][Full Text] [Related]
13. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.
Lai CY; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Tsao SW; Cheung AN
Mod Pathol; 2004 Jan; 17(1):40-8. PubMed ID: 14631372
[TBL] [Abstract][Full Text] [Related]
14. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.
Xing D; Miller K; Beierl K; Ronnett BM
Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808
[TBL] [Abstract][Full Text] [Related]
15. Androgenetic Complete Hydatidiform Moles With p57KIP2-Positive Immunostaining.
Usui H; Sato A; Ota M; Ikeda JI; Shozu M
Am J Clin Pathol; 2020 Nov; 154(6):776-783. PubMed ID: 32686837
[TBL] [Abstract][Full Text] [Related]
16. Tetraploid partial hydatidiform mole: a case report and review of the literature.
Murphy KM; Descipio C; Wagenfuehr J; Tandy S; Mabray J; Beierl K; Micetich K; Libby AL; Ronnett BM
Int J Gynecol Pathol; 2012 Jan; 31(1):73-9. PubMed ID: 22123726
[TBL] [Abstract][Full Text] [Related]
17. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay.
Murphy KM; McConnell TG; Hafez MJ; Vang R; Ronnett BM
J Mol Diagn; 2009 Nov; 11(6):598-605. PubMed ID: 19815697
[TBL] [Abstract][Full Text] [Related]
18. Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM).
Chew SH; Perlman EJ; Williams R; Kurman RJ; Ronnett BM
Hum Pathol; 2000 Aug; 31(8):914-24. PubMed ID: 10987251
[TBL] [Abstract][Full Text] [Related]
19. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis.
Cheung AN; Khoo US; Lai CY; Chan KY; Xue WC; Cheng DK; Chiu PM; Tsao SW; Ngan HY
Cancer; 2004 Apr; 100(7):1411-7. PubMed ID: 15042675
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.
Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM
Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
